Testosterone Replacement Therapy: The Complete Guide

Your doctor said your testosterone is "normal." But you're exhausted, you've gained 20 pounds in two years, your libido has gone quiet, and lifting weights doesn't feel like it changes anything. You've done the Reddit research, watched the YouTube deep dives, and now you want the actual clinical picture, not a sales pitch.

This guide covers everything physicians actually look at when evaluating testosterone replacement therapy: what labs you need, how to interpret them, how each delivery method works, what the landmark 2023 TRAVERSE trial says about long-term safety, and what it realistically costs to get started. No bro-science. No fear-mongering. Just the clinical facts, explained clearly.

What Is Testosterone Replacement Therapy?

Testosterone replacement therapy (TRT) is physician-prescribed testosterone given to men (and in some contexts, women) whose bodies aren't producing adequate levels of the hormone. The goal is to restore testosterone to a physiologic range, not to push levels above natural limits.

This distinction matters. Supraphysiologic doses of testosterone carry meaningfully different risks than physiologic replacement. High-dose exogenous testosterone suppresses HDL cholesterol and disrupts normal spermatogenesis in ways that physiologic replacement does not (Bagatell et al., 1994). Most of what you've heard about "steroids" refers to the former. TRT, done correctly, is something else entirely.

The FDA has approved testosterone for treating hypogonadism (the clinical term for testosterone deficiency) in men (Nieschlag et al., 2004). The approved products include injectable solutions, topical gels, transdermal patches, subcutaneous pellets, nasal gels, and buccal systems. Each has a different pharmacokinetic profile, cost structure, and administration burden.

The Labs You Need Before Starting

Before any provider writes a prescription, you need a baseline blood panel. This isn't optional. It's how treatment decisions get made, and it's how you protect yourself over time.

The core labs for TRT evaluation:

• Total testosterone: the standard starting point. Labs use different reference ranges, but most consider below 300 ng/dL to be low. The critical detail: "in range" at 310 ng/dL is not the same as optimal.
• Free testosterone: the biologically active fraction. Estimated from total testosterone and SHBG. This matters more than total T for men with elevated SHBG.
• SHBG (sex hormone-binding globulin): determines how much of your total T is actually available to your cells. High SHBG can make your total testosterone look fine while your free testosterone is low.
• Estradiol (E2): testosterone converts to estradiol via aromatase. You need a baseline before starting, and monitoring afterward. Too low causes joint pain and mood issues; too high causes water retention and can affect libido.
• Hematocrit: TRT raises red blood cell production. Hematocrit above 54% is a monitoring threshold that may require dose adjustment or a therapeutic phlebotomy.
• PSA (prostate-specific antigen): baseline PSA is required for men over 40. Testosterone does not cause prostate cancer, but it can accelerate growth of an existing cancer. A well-designed RCT found no significant change in prostate tissue androgen levels after six months of TRT (Marks et al., 2006).
• LH and FSH: these pituitary hormones tell you whether low testosterone is primary (testicular failure) or secondary (pituitary/hypothalamic issue). This matters for choosing treatment.

Dr. Kyle Gillett, a board-certified family and obesity medicine physician, recommends also checking vitamin D, zinc, and cortisol before concluding TRT is necessary (Gillett, Huberman Lab). Nutrient deficiencies can suppress testosterone, and addressing those first is a reasonable first step for men with borderline levels.

If your doctor isn't ordering at minimum total T, free T, SHBG, estradiol, hematocrit, and PSA before writing a prescription, find a different provider. You can learn more about how to test your testosterone levels and what the numbers actually mean.

How to Know If You Actually Need TRT

The diagnosis of hypogonadism requires two things: a low testosterone level confirmed on two separate morning draws, and symptoms consistent with deficiency. Symptoms alone aren't enough. A low number alone isn't enough either.

Common symptoms that drive men to get tested include persistent fatigue, loss of muscle despite consistent training, accumulating abdominal fat, low libido, poor sleep quality, and mood changes that feel out of character. These overlap with a lot of other conditions, which is why the lab work matters.

The reference range problem is real. The "normal" range used by most US labs runs from roughly 270-1,070 ng/dL. A 45-year-old man at 310 ng/dL is technically in range. Most men in that situation feel considerably worse than they did at 600-700 ng/dL. The range captures what's observed in a population, not what's optimal.

Peter Attia, MD, a longevity physician, makes the point that free testosterone and total testosterone don't always tell the same story (Attia, 2024). "You don't know how many androgen receptors you have," he notes, "so you really don't have any idea how much testosterone is saturating them." This is why symptom assessment alongside labs matters, not labs alone.

If your levels are borderline and you're symptomatic, it's worth understanding the signs of hormone imbalance that go beyond just testosterone.

Delivery Methods: How TRT Is Actually Administered

Testosterone replacement therapy comes in six primary delivery formats. The method you use affects cost, convenience, how stable your levels stay, and certain side effect profiles.

Intramuscular Injections (Testosterone Cypionate or Enanthate)

The most prescribed and cost-effective method. Testosterone cypionate and enanthate are long-acting esters injected into muscle, typically the glute, every 1-2 weeks. More frequent dosing (every 3-7 days) produces more stable levels and is preferred by most informed clinicians.

Standard medical dosing starts around 100-150 mg per week and is adjusted based on follow-up labs (Bhasin & Bremner, 1997). Derek from More Plates More Dates, who covers TRT protocols in depth, uses 120 mg per week of testosterone enanthate split into every-other-day injections. This frequency avoids the trough-peak cycle that can cause mood and energy fluctuations on less frequent injections.

Pros: Lowest cost, dose flexibility, widely available through compounding pharmacies. Cons: Self-injection is required, levels fluctuate more on weekly dosing.

Subcutaneous Injections

The same testosterone cypionate or enanthate administered with a smaller insulin needle into the subcutaneous fat layer of the abdomen or thigh rather than muscle. Absorption is slightly slower, producing a flatter pharmacokinetic curve. Many men find subcutaneous injections easier to perform and more comfortable than intramuscular.

Topical Gels (AndroGel, Testim, Fortesta)

Applied daily to the shoulders, upper arms, or inner thighs. More convenient than injections but can transfer to partners or children through skin contact. This is a genuine safety concern that requires care with application and hand-washing. Levels are more stable than weekly injections but require daily adherence.

Brand-name gels are expensive (often $400-600+/month without insurance). Generic alternatives exist.

Transdermal Patches (Androderm)

Applied nightly to the skin. Produces relatively stable testosterone levels with less transfer risk than gels. Some patients develop skin irritation at application sites.

Testosterone Pellets (Testopel)

Small pellets implanted subcutaneously in the hip or buttock area by a provider, typically every 3-6 months. Extremely convenient from a patient perspective but dose is not adjustable once implanted. If you need a change, you wait for the pellets to dissolve.

Nasal and Buccal Systems (Natesto, Jatenzo)

Newer delivery options. Natesto is a nasal gel applied three times daily. Jatenzo is an oral capsule taken with meals. These have smaller market share and higher costs, but the nasal route preserves LH and FSH more than other methods, which may be relevant for men concerned about fertility.

For a deeper look at how the delivery methods compare head-to-head on cost, convenience, and level stability, see the full guide to TRT delivery methods.

The 2023 TRAVERSE Trial: What It Actually Says About Safety

The most important TRT safety data published in decades came from the TRAVERSE trial (Lincoff et al., 2023), a 5,204-patient randomized controlled trial published in the New England Journal of Medicine. This was the study the FDA required to answer the cardiovascular safety question definitively.

The headline finding: testosterone replacement therapy did not significantly increase the rate of major adverse cardiovascular events (MACE) compared to placebo in hypogonadal men with existing or high cardiovascular risk. Heart attack and stroke risk did not go up.

That's the good news. The trial also found two signals worth taking seriously:

Venous thromboembolism (VTE): The TRT group had a higher rate of blood clots (deep vein thrombosis and pulmonary embolism) than placebo. This was a statistically significant finding and aligns with what's known about testosterone's effects on red blood cell production and clotting factors.

Atrial fibrillation: Higher rates of atrial fibrillation were observed in the testosterone group compared to placebo.

For most men being evaluated for TRT, the TRAVERSE cardiovascular data is reassuring. For men with a personal or strong family history of VTE or atrial fibrillation, these specific findings warrant a more careful risk-benefit conversation with a physician.

The FDA's FAERS database contains over 51,161 adverse event reports associated with testosterone products. This number includes everything from expected side effects (acne, hematocrit elevation) to serious events. Transparent reporting exists. The task is interpreting it in clinical context, which is what physician oversight is for.

Is TRT Safe Long-Term?

For appropriately selected men at physiologic doses, the current evidence says yes, with regular monitoring. The TRAVERSE data provides the clearest long-term signal we have.

Earlier cardiovascular safety concerns were significantly addressed by TRAVERSE's findings. Two older concerns, prostate cancer and heart disease, deserve specific commentary.

Prostate: A rigorous RCT enrolled 44 hypogonadal men with testosterone under 300 ng/dL, randomized to testosterone enanthate or placebo for six months with biopsies at baseline and endpoint. Prostate tissue androgen levels did not meaningfully increase, and there were no significant changes in prostate histology (Marks et al., 2006). This supports the "saturation model": prostate tissue has limited androgen receptor availability, and additional testosterone doesn't drive further growth in most men.

Cardiovascular: Earlier small trials suggested possible benefit. A double-blind RCT of 76 men with heart failure found TRT improved exercise capacity by 15% versus placebo, with symptom improvement in 35% of men on testosterone versus 8% on placebo (Malkin et al., 2006). A separate trial showed TRT in hypogonadal men with angina extended time to ischemic threshold by 74 seconds versus placebo (Malkin et al., 2004). These were small studies. The TRAVERSE trial's 5,204-patient sample makes its findings the most credible data on cardiovascular safety at the population level. MACE was not significantly elevated. VTE and a-fib were.

Metabolic: A randomized controlled trial of 94 men with type 2 diabetes found that TRT improved insulin sensitivity by 32%, decreased subcutaneous fat mass by 3.3 kg, and increased lean mass by 3.4 kg over 24 weeks (Dhindsa et al., 2015). A separate RCT in 199 diabetic men found significant improvements in erectile function and quality of life with testosterone undecanoate versus placebo (Hackett et al., 2013).

Hematocrit is the most common monitoring target. TRT stimulates erythropoiesis. If hematocrit climbs above 54%, most protocols recommend dose reduction, a break from treatment, or therapeutic phlebotomy. This is why regular blood monitoring isn't optional. It's how you catch the most common serious risk before it becomes a problem.

TRT and Fertility: What You Need to Know

Exogenous testosterone suppresses the body's natural production of LH and FSH, which in turn suppresses spermatogenesis. For men who are trying to conceive or want to preserve that option, this is one of the most important conversations to have before starting TRT.

Standard TRT will reduce or eliminate sperm production in most men within a few months of starting. This is not permanent. Sperm counts typically recover after stopping, but recovery can take 6-18 months and is not guaranteed for all men.

Human chorionic gonadotropin (HCG) mimics LH and can maintain intratesticular testosterone production alongside TRT, preserving some spermatogenesis. It's typically added to TRT protocols for men who want to maintain fertility or avoid testicular atrophy. HCG is often dosed at 500-1,000 IU twice or three times per week.

Enclomiphene is an alternative for men who don't want to start TRT at all. It's a selective estrogen receptor modulator (SERM) that blocks estrogen feedback at the pituitary, causing the body to produce more LH and FSH naturally, which then stimulates testosterone production. For men with secondary hypogonadism, enclomiphene can restore testosterone levels without suppressing sperm production. You can read the full enclomiphene guide for a detailed look at how it compares.

If you're under 35 and considering TRT, fertility preservation is not a side conversation. It should be part of the initial protocol discussion.

Common Side Effects and How to Manage Them

Most TRT side effects are dose-dependent and manageable with proper monitoring. Here are the ones worth knowing before you start.

Hematocrit elevation is the most clinically significant. Regular CBC monitoring (every 3-6 months while stable) catches this. If your hematocrit exceeds 52-54%, your provider will adjust your dose or recommend a phlebotomy. Staying well-hydrated reduces risk.

Estradiol elevation occurs when testosterone aromatizes (converts to estrogen) at a higher rate than your body manages. Symptoms include water retention, mood changes, and sensitive nipples. Not everyone needs an aromatase inhibitor (AI). Many men do fine without one. AI use should be guided by estradiol lab values, not assumed.

Acne is common, particularly on the back and shoulders. It typically peaks in the first few months and improves. It's related to androgen activity on sebaceous glands.

Testicular atrophy happens because exogenous testosterone signals the body to shut down its own production. The testes reduce in size when they're no longer producing testosterone. HCG can partially prevent this.

Hair loss: TRT can accelerate male-pattern baldness in men who are genetically predisposed. DHT (dihydrotestosterone), converted from testosterone by 5-alpha reductase, is the driver. Finasteride or dutasteride can mitigate this if hair preservation is a priority.

Sleep apnea can worsen on TRT. If you snore heavily or have been diagnosed with apnea, mention this to your provider.

The framing here matters: these are manageable side effects at physiologic doses, not reasons to avoid TRT if you genuinely need it. The question is always risk versus benefit in your specific situation.

Lab Monitoring Schedule on TRT

Once you've started treatment, labs don't stop. This is where TRT differs from a lot of other prescriptions: it requires ongoing monitoring to be done safely.

6-8 weeks after starting:

• Total testosterone (trough if on injections; draw the morning of your next scheduled dose)
• Free testosterone
• Estradiol
• Hematocrit/CBC

3 months after starting:

• Repeat the above panel
• PSA (for men over 40)
• Adjust dose based on results

Every 6-12 months once stable:

• Full panel including SHBG, metabolic panel, lipids
• PSA annually for men over 40
• Continue hematocrit monitoring

Target total testosterone for most men on TRT sits in the 600-900 ng/dL range on trough values, though individual optimization varies. Research on men with early Alzheimer's disease found quality-of-life improvements with testosterone gel compared to placebo, suggesting cognitive and mood benefits extend beyond physical symptoms (Lu et al., 2006). Free testosterone targets are more nuanced and provider-dependent. Many physicians track how you feel alongside the numbers rather than chasing a specific numerical target.

Cost, Insurance Coverage, and How to Access TRT

This is the part most guides skip. Here's the honest picture.

Injections via compounding pharmacies are the most affordable option. Testosterone cypionate or enanthate from a compounding pharmacy typically runs $50-150 per month, depending on dose and concentration. This is the method most telemedicine TRT providers use.

Brand-name topical gels (AndroGel, Testim) are expensive without insurance, often $400-600+ per month. With insurance coverage under a hypogonadism diagnosis, out-of-pocket can drop significantly. Check your specific plan.

Insurance coverage generally requires a confirmed hypogonadism diagnosis (ICD-10 code E29.1). Insurance will usually cover at least one of the FDA-approved testosterone formulations with appropriate documentation. Coverage varies widely by plan and state.

Telemedicine TRT clinics have made access significantly more convenient. Providers like Marek Health, Defy Medical, and Hone Health operate nationally and can prescribe and ship compounded testosterone directly to patients. Costs typically include a consultation fee plus the monthly medication cost. These are legitimate medical practices, not supplement shops.

HEXIS Health offers physician-guided TRT for men in Montana, Idaho, Washington, and Oregon. Your protocol starts with a full lab panel reviewed by a licensed provider who builds your treatment plan around your actual numbers. Schedule a consultation to get started.

The Low Testosterone Symptoms That Often Get Missed

One reason men go years before getting tested: the symptoms of low testosterone are diffuse and overlap with other common conditions.

Fatigue? Probably stress. Brain fog? Not enough sleep. Loss of muscle despite training? Could be diet. Mood changes? Hard to pin down. By the time the picture becomes clear, some men have been told everything is "normal" by three different physicians.

The clearest signal is the combination: persistent fatigue that doesn't improve with adequate sleep, progressive loss of muscle mass and strength despite consistent effort, accumulation of fat particularly around the abdomen, significantly reduced libido, and a general sense of not feeling like yourself. When multiple symptoms line up, labs are warranted.

The low testosterone symptoms guide covers the full clinical picture with more detail than this guide can hold, including the often-missed psychological symptoms and how symptom severity correlates with lab values.

Frequently Asked Questions

How long does it take for TRT to work?

Most men notice improved energy and mood within 3-6 weeks of starting testosterone replacement therapy. Libido improvements often come in the 4-8 week window. Body composition changes (increased muscle and reduced fat) take longer, typically becoming measurable at the 3-month mark with continued improvement over 6-12 months. Lab values typically normalize within 6-8 weeks of the correct dose.

What is a typical starting TRT dose?

The standard starting dose for injectable testosterone is 100-150 mg per week of testosterone cypionate or enanthate. Many physicians now recommend splitting this into smaller, more frequent doses (every 2-3 days) to avoid level peaks and troughs. Dose is adjusted at the 6-8 week lab check based on total T, free T, estradiol, and hematocrit results. Starting conservatively and adjusting up is the correct approach.

Is TRT safe long-term? What does the TRAVERSE trial show?

The TRAVERSE trial (Lincoff et al., 2023), which enrolled 5,204 hypogonadal men and ran for nearly five years, found no significant increase in major cardiovascular events (heart attack, stroke, cardiovascular death) compared to placebo. This is the largest safety trial ever conducted on TRT. The same trial did find higher rates of venous blood clots and atrial fibrillation in the testosterone group, which warrants attention in men with those specific risk factors.

Will TRT make me infertile?

TRT suppresses the body's own testosterone production, which also reduces sperm production significantly. Most men's sperm counts decline substantially within 3-6 months of starting. Recovery after stopping TRT typically takes 6-18 months and is not guaranteed. Men who want to preserve fertility can add HCG to their protocol or consider enclomiphene as an alternative to TRT.

Do I need an aromatase inhibitor on TRT?

Not necessarily. Many men on physiologic TRT doses do not need an aromatase inhibitor. The decision should be based on estradiol lab values, not assumed. If estradiol is within normal range and you have no symptoms of excess estrogen, an AI is usually not indicated. Over-suppression of estrogen causes its own problems including joint pain, low libido, and cardiovascular risk.